Strain | Average reduction of log10 (cfu/ml) at 400 MPa | CRISPR/Cas systems | Number of spacers | Self-targeting spacer predicted | anti-CRISPR gene predicted | Number of prophage predicted |
---|---|---|---|---|---|---|
RO15 | 0.05 | RliB-CRISPR, CRISPR I | 64 | yes | AcrIIA1, A2 | 5 |
2HF33 | 0.15 | RliB-CRISPR, CRISPR I, CRISPR II | 62 | yes | AcrIIA1, A2, A3, A4 | 5 |
MB5 | 0.22 | RliB-CRISPR, CRISPR II | 39 | yes | AcrIIA1, A2, A3 | 5 |
AB199 | 0.26 | RliB-CRISPR | 3 | no | no | 1 |
AB120 | 0.35 | RliB-CRISPR | 3 | no | no | 1 |
C7 | 0.37 | RliB-CRISPR | 7 | no | no | 6 |
F2365 | 0.47 | RliB-CRISPR | 3 | no | no | 1 |
ScottA | 0.68 | RliB-CRISPR | 3 | no | no | 3 |
RO4 | 1.00 | RliB-CRISPR | 5 | no | AcrIIA1, A2, A3 | 1 |
EGD-e | 2.07 | RLIB-CRISPR | 4 | no | AcrIIA1, A2, A3 | 2 |